Cullen/Frost Bankers’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-130
Closed -$13.2K 1443
2025
Q4
$13.2K Hold
130
﹤0.01% 1081
2025
Q3
$7.11K Hold
130
﹤0.01% 1127
2025
Q2
$6.91K Hold
130
﹤0.01% 1070
2025
Q1
$5.63K Hold
130
﹤0.01% 1026
2024
Q4
$7.3K Hold
130
﹤0.01% 934
2024
Q3
$8.86K Hold
130
﹤0.01% 911
2024
Q2
$5.49K Buy
130
+24
+23% +$1.32K ﹤0.01% 935
2024
Q1
$7.32K Buy
+106
New +$6.71K ﹤0.01% 833
2023
Q4
Sell
-700
Closed -$47.8K 1064
2023
Q3
$47.8K Buy
700
+200
+40% +$17K ﹤0.01% 731
2023
Q2
$47K Buy
+500
New +$39K ﹤0.01% 739
2022
Q4
Sell
-11
Closed 1136
2022
Q3
$0 Buy
+11
New +$454 ﹤0.01% 1157
2020
Q3
Sell
-18
Closed -$2K 1182
2020
Q2
$2K Sell
18
-175
-91% -$14K ﹤0.01% 1019
2020
Q1
$11K Buy
193
+28
+17% +$2.27K ﹤0.01% 709
2019
Q4
$15K Buy
+165
New +$14.5K ﹤0.01% 836

Other funds holding EXAS

Cullen/Frost Bankers's EXAS Position: Q1 2026 in Review

Cullen/Frost Bankers sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 130 shares — an estimated $13.2K sold.

Cullen/Frost Bankers first reported a position in EXAS in Q4 2019 and held it in 14 quarters. The position peaked at $47.8K in Q3 2023. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • Cullen/Frost Bankers reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • Cullen/Frost Bankers sold 130 Exact Sciences shares in Q1 2026, an estimated $13.2K.
  • Cullen/Frost Bankers first reported a position in Exact Sciences in Q4 2019 and held it in 14 quarters.
  • Cullen/Frost Bankers's Exact Sciences position peaked at $47.8K in Q3 2023.
  • 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on Cullen/Frost Bankers's 13F filing for Q1 2026, filed 5 May 2026.